<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05017220</url>
  </required_header>
  <id_info>
    <org_study_id>NBS in chronic pain patients</org_study_id>
    <nct_id>NCT05017220</nct_id>
  </id_info>
  <brief_title>Nature-based Sensory Stimulation on Pain Levels</brief_title>
  <official_title>The Effects of Nature-based Sensory Stimulation on Pain in Women With Fibromyalgia: A Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad de Granada</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad de Granada</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized controlled trial aims to evaluate the effect of a single session intervention&#xD;
      based on a nature-based stimulation program in patients with fibromyalgia&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All participants will continue to receive their usual pharmacological treatment as previously&#xD;
      established by the Andalusian Public Health System. The intervention will comprise&#xD;
      interaction tasks with biotic and abiotic agents for 30 minutes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 15, 2021</start_date>
  <completion_date type="Actual">August 31, 2021</completion_date>
  <primary_completion_date type="Actual">August 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain intensity</measure>
    <time_frame>Change from baseline pain intensity after 30 minutes</time_frame>
    <description>Clinical pain intensity assessed by an 11-points Numeric Rating Scale (NRS-11) ranging from 0 to 10</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cold pain thresholds</measure>
    <time_frame>Change from baseline cold pain thresholds after 30 minutes</time_frame>
    <description>Cold pressor test will be used</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Punctate mechanical hyperalgesia</measure>
    <time_frame>Change from baseline mechanical hyperalgesia after 30 minutes</time_frame>
    <description>Semmes-Weinstein monofilament (Aesthesio® Precise Tactile Sensory Evaluator, DanMic Global, LLC, San Jose, CA, USA) calibrated to bend at 300 gm (2940 mN; size 6.65; 0.1143 cm in diameter) of pressure with a response-dependent method will be used</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Wind-up phenomenon</measure>
    <time_frame>Change from baseline temporal summation of pain perception after 30 minutes</time_frame>
    <description>Wind-up is a frequency- and intensity-dependent increase in the excitability of dorsal horn neuron that results in a temporal summation of pain perception.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pressure pain thresholds</measure>
    <time_frame>Change from baseline pressure pain thresholds after 30 minutes</time_frame>
    <description>The minimum pressure force which induces pain when pressure is applied on tissues is regarded as the pressure pain threshold</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">42</enrollment>
  <condition>Fibromyalgia</condition>
  <arm_group>
    <arm_group_label>Nature-based stimulation program</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive a single intervention with a duration of 30 minutes based on a multisensorial nature-based stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control intervention</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Participants will be involved in a placebo task for 30 minutes</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nature-based sensory stimuli</intervention_name>
    <description>A program based on stimulation using nature-based sensory stimuli will be implemented</description>
    <arm_group_label>Nature-based stimulation program</arm_group_label>
    <other_name>Biogenic sensory stimuli</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control group intervention</intervention_name>
    <description>An activity based on a placebo intervention will be implemented</description>
    <arm_group_label>Control intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of fibromyalgia syndrome (ACR criteria 2016).&#xD;
&#xD;
          -  Chronic widespread musculoskeletal pain symptoms (&gt;1 location using the Widespread&#xD;
             Pain Index).&#xD;
&#xD;
          -  High-intensity pain (VAS ≥ 4), at least 3 days a week for the previous 3 months.&#xD;
&#xD;
          -  If currently taking analgesic or psychotropic medications, they had to be stabilised&#xD;
             for four or more weeks before the study enrolment&#xD;
&#xD;
          -  Over 18 and less than 65 years old (labour active).&#xD;
&#xD;
          -  Ability to speak and understand English or Spanish.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Acute or temporal pain&#xD;
&#xD;
          -  Severe cognitive impairment, detected by the Mini-Mental State Examination (score &lt;24&#xD;
             out of 30 points)&#xD;
&#xD;
          -  Severe mental disorders in acute phase or symptomatic phase&#xD;
&#xD;
          -  Behavioural alterations as this may interfere in their participation&#xD;
&#xD;
          -  Severe intellectual disability&#xD;
&#xD;
          -  Other severe or medically unstable diseases interfering with the project participation&#xD;
&#xD;
          -  Co-occurrence of neuropathic pain&#xD;
&#xD;
          -  Other disorders that may cause pain&#xD;
&#xD;
          -  Pregnant or breast-feeding&#xD;
&#xD;
          -  Drug abuse within the past year.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Faculty of Health Sciences</name>
      <address>
        <city>Granada</city>
        <zip>18008</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universidad de Granada</name>
      <address>
        <city>Granada</city>
        <zip>18008</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 5, 2021</study_first_submitted>
  <study_first_submitted_qc>August 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 23, 2021</study_first_posted>
  <last_update_submitted>September 30, 2021</last_update_submitted>
  <last_update_submitted_qc>September 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad de Granada</investigator_affiliation>
    <investigator_full_name>José Manuel Pérez Mármol</investigator_full_name>
    <investigator_title>Principal Investigator / Associate professor</investigator_title>
  </responsible_party>
  <keyword>Fibromyalgia</keyword>
  <keyword>Nature-based activities</keyword>
  <keyword>Pain dimensions</keyword>
  <keyword>Multisensory stimulation</keyword>
  <keyword>Quantitative sensory testing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibromyalgia</mesh_term>
    <mesh_term>Myofascial Pain Syndromes</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

